The incremental benefit beyond established risk markers must be rigorously demonstrated in prospective studies before widespread adoption ( Ultimately, while these technologies represent breakthroughs in DKD risk prediction and early detection, their clinical success hinges on overcoming challenges related to generalizability, bias, interpretability, and regulatory approval
Your body ramps up collagen production, growth factor release, and stem cell activity
Since Mounjaro was licensed for use for weight management in the UK in 2023 it has become the most widely used weight-loss drug
Before starting to take semaglutide GLP-1 treatment, it is important to keep in mind that its results are not immediate, but do work quickly over the course of several months
See if these injections are right for your goals in our guide
doi: 10.1016/j.jfms.2009.04.004